Integral Diagnostics Past Earnings Performance
Past criteria checks 0/6
Integral Diagnostics's earnings have been declining at an average annual rate of -24.6%, while the Healthcare industry saw earnings growing at 5% annually. Revenues have been growing at an average rate of 14.9% per year.
Key information
-24.6%
Earnings growth rate
-28.4%
EPS growth rate
Healthcare Industry Growth | 8.5% |
Revenue growth rate | 14.9% |
Return on equity | -19.3% |
Net Margin | -12.7% |
Next Earnings Update | 27 Aug 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Integral Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 456 | -58 | 26 | 0 |
30 Sep 23 | 449 | -16 | 26 | 0 |
30 Jun 23 | 441 | 25 | 25 | 0 |
31 Mar 23 | 418 | 23 | 24 | 0 |
31 Dec 22 | 395 | 21 | 22 | 0 |
30 Sep 22 | 378 | 18 | 21 | 0 |
30 Jun 22 | 361 | 15 | 21 | 0 |
31 Mar 22 | 361 | 18 | 21 | 0 |
31 Dec 21 | 360 | 22 | 22 | 0 |
30 Sep 21 | 356 | 26 | 22 | 0 |
30 Jun 21 | 351 | 31 | 22 | 0 |
31 Mar 21 | 333 | 32 | 21 | 0 |
31 Dec 20 | 315 | 32 | 19 | 0 |
30 Sep 20 | 295 | 28 | 18 | 0 |
30 Jun 20 | 276 | 23 | 16 | 0 |
31 Mar 20 | 263 | 22 | 18 | 0 |
31 Dec 19 | 250 | 21 | 19 | 0 |
30 Sep 19 | 241 | 21 | 21 | 0 |
30 Jun 19 | 232 | 21 | 24 | 0 |
31 Mar 19 | 222 | 19 | 23 | 0 |
31 Dec 18 | 211 | 17 | 23 | 0 |
30 Sep 18 | 200 | 16 | 22 | 0 |
30 Jun 18 | 189 | 15 | 21 | 0 |
31 Mar 18 | 187 | 15 | 21 | 0 |
31 Dec 17 | 185 | 15 | 20 | 0 |
30 Sep 17 | 182 | 15 | 20 | 0 |
30 Jun 17 | 180 | 15 | 20 | 0 |
31 Mar 17 | 177 | 16 | 19 | 0 |
31 Dec 16 | 175 | 16 | 19 | 0 |
30 Sep 16 | 171 | 14 | 18 | 0 |
30 Jun 16 | 168 | 11 | 18 | 0 |
31 Mar 16 | 165 | 11 | 17 | 0 |
31 Dec 15 | 162 | 11 | 17 | 0 |
30 Sep 15 | 157 | 8 | 17 | 0 |
30 Jun 15 | 151 | 5 | 16 | 0 |
30 Jun 14 | 4 | 3 | 1 | 0 |
Quality Earnings: ITGD.F is currently unprofitable.
Growing Profit Margin: ITGD.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ITGD.F is unprofitable, and losses have increased over the past 5 years at a rate of 24.6% per year.
Accelerating Growth: Unable to compare ITGD.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ITGD.F is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (6%).
Return on Equity
High ROE: ITGD.F has a negative Return on Equity (-19.26%), as it is currently unprofitable.